Celltrion, Stock Price Down 1.36% at This Time... Foreigners Net Buy 370,142 Shares in Last 5 Days

As of 10:32 AM on the 17th, Celltrion is trading at 289,500 KRW, down 1.36% from the previous day. The trading volume is 721,026 shares, which is about 36.6% of the previous day's volume. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

On June 17, researcher Lee Dal-mi from SK Securities stated, "Acquired Takeda Primary Care Asia-Pacific division. Obtained all rights to 12 original prescription drug brands and 6 over-the-counter drug brands. This acquisition is expected to propel the company into a global comprehensive pharmaceutical company. The continued strong performance growth through the second half of the year, short-selling ban, and development of COVID-19 treatments are expected to serve as positive momentum for stock price increases in the latter half of the year." Lee set Celltrion's target price at 370,000 KRW.

Over the past five days, individual investors have net sold 109,634 shares of Celltrion, while foreign investors and institutions have net bought 370,142 shares and net sold 230,787 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.